Nom du produit:N-(4-methoxyphenyl)-3-oxobutanamide
IUPAC Name:N-(4-methoxyphenyl)-3-oxobutanamide
- CAS:5437-98-9
- Formule moléculaire:C11H13NO3
- Pureté:95%+
- Numéro de catalogue:CM341153
- Poids moléculaire:207.23
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:5437-98-9
- Formule moléculaire:C11H13NO3
- Point de fusion:-
- Code SMILES:CC(CC(NC1=CC=C(OC)C=C1)=O)=O
- Densité:
- Numéro de catalogue:CM341153
- Poids moléculaire:207.23
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Benzenes
- Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.
Column Infos
- Tafenoquine
- 60 Degrees Pharmaceuticals recently announced it has entered into an agreement with Tufts Medical Center in Boston to conduct the world’s first clinical trial evaluating the efficacy and safety of tafenoquine in treating human babesiosis patients. The FDA has granted its investigational tafenoquine candidate orphan drug designation for the treatment of patients with acute babesiosis.
Tafenoquine was approved for malaria prophylaxis in 2018 in the United States as ARAKODA and in Australia as KODATEF. It is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older.